rs3852700
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_013241.3(FHOD1):c.642+79A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.108 in 1,495,948 control chromosomes in the GnomAD database, including 20,899 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.24 ( 8942 hom., cov: 33)
Exomes 𝑓: 0.093 ( 11957 hom. )
Consequence
FHOD1
NM_013241.3 intron
NM_013241.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.262
Genes affected
FHOD1 (HGNC:17905): (formin homology 2 domain containing 1) This gene encodes a protein which is a member of the formin/diaphanous family of proteins. The gene is ubiquitously expressed but is found in abundance in the spleen. The encoded protein has sequence homology to diaphanous and formin proteins within the Formin Homology (FH)1 and FH2 domains. It also contains a coiled-coil domain, a collagen-like domain, two nuclear localization signals, and several potential PKC and PKA phosphorylation sites. It is a predominantly cytoplasmic protein and is expressed in a variety of human cell lines. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
SLC9A5 (HGNC:11078): (solute carrier family 9 member A5) Predicted to enable potassium:proton antiporter activity and sodium:proton antiporter activity. Predicted to be involved in potassium ion transmembrane transport; regulation of intracellular pH; and sodium ion import across plasma membrane. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. Implicated in end stage renal disease. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.628 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHOD1 | ENST00000258201.9 | c.642+79A>G | intron_variant | Intron 6 of 21 | 1 | NM_013241.3 | ENSP00000258201.4 | |||
SLC9A5 | ENST00000564704.5 | n.273T>C | non_coding_transcript_exon_variant | Exon 1 of 16 | 1 | |||||
FHOD1 | ENST00000561922.1 | n.*155+79A>G | intron_variant | Intron 6 of 12 | 2 | ENSP00000458085.1 | ||||
FHOD1 | ENST00000567752.5 | n.1223+79A>G | intron_variant | Intron 4 of 19 | 2 |
Frequencies
GnomAD3 genomes AF: 0.235 AC: 35750AN: 152066Hom.: 8906 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
35750
AN:
152066
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0931 AC: 125158AN: 1343764Hom.: 11957 Cov.: 21 AF XY: 0.0933 AC XY: 62682AN XY: 671554 show subpopulations
GnomAD4 exome
AF:
AC:
125158
AN:
1343764
Hom.:
Cov.:
21
AF XY:
AC XY:
62682
AN XY:
671554
Gnomad4 AFR exome
AF:
AC:
20321
AN:
30958
Gnomad4 AMR exome
AF:
AC:
4153
AN:
43446
Gnomad4 ASJ exome
AF:
AC:
961
AN:
24360
Gnomad4 EAS exome
AF:
AC:
731
AN:
39056
Gnomad4 SAS exome
AF:
AC:
13933
AN:
81860
Gnomad4 FIN exome
AF:
AC:
5919
AN:
52688
Gnomad4 NFE exome
AF:
AC:
72607
AN:
1011098
Gnomad4 Remaining exome
AF:
AC:
6143
AN:
56022
Heterozygous variant carriers
0
5627
11253
16880
22506
28133
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2830
5660
8490
11320
14150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.236 AC: 35846AN: 152184Hom.: 8942 Cov.: 33 AF XY: 0.233 AC XY: 17356AN XY: 74410 show subpopulations
GnomAD4 genome
AF:
AC:
35846
AN:
152184
Hom.:
Cov.:
33
AF XY:
AC XY:
17356
AN XY:
74410
Gnomad4 AFR
AF:
AC:
0.634323
AN:
0.634323
Gnomad4 AMR
AF:
AC:
0.122206
AN:
0.122206
Gnomad4 ASJ
AF:
AC:
0.0342742
AN:
0.0342742
Gnomad4 EAS
AF:
AC:
0.0210506
AN:
0.0210506
Gnomad4 SAS
AF:
AC:
0.165837
AN:
0.165837
Gnomad4 FIN
AF:
AC:
0.122642
AN:
0.122642
Gnomad4 NFE
AF:
AC:
0.0711051
AN:
0.0711051
Gnomad4 OTH
AF:
AC:
0.17315
AN:
0.17315
Heterozygous variant carriers
0
947
1894
2840
3787
4734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
304
608
912
1216
1520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
518
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at